Modeling of corneal and retinal pharmacokinetics after periocular drug administration
about
Episcleral clearance of sodium fluorescein from a bioerodible sub-tenon's implant in the rat.Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerveRecent advances in ophthalmic drug delivery.Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroidsInhibition of corneal neovascularization with the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile INTeraction-18 (p-PEDF-SAINT-18) vector in a rat corneal experimental angiogenesis model.Influence of dosage form on the intravitreal pharmacokinetics of diclofenac.Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetesNanomedicines for back of the eye drug delivery, gene delivery, and imaging.Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection.Prediction of passive drug permeability across the blood-retinal barrier.Tissue disposition of the insect repellent DEET and the sunscreen oxybenzone following intravenous and topical administration in rats.Intraocular distribution of melanin in human, monkey, rabbit, minipig and dog eyes.Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration.Principles of pharmacology in the eye.Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.Sustained and targeted episcleral delivery of celecoxib in a rabbit model of retinal and choroidal neovascularization
P2860
Q33523210-18BDCDF3-95B6-4638-A8FB-ED506FC402E5Q33714957-6372707C-838D-4DF2-9A43-2DF0C7A6178DQ34636338-E7874CC3-9C08-400D-A2E4-DBD2B8007C97Q34856993-B71245DD-E5DD-4FEF-98C7-F049DB2810ECQ36820584-AE11E44A-1AE6-4938-A7E2-81AA9E996310Q37399016-9DCA56E2-14E6-47BC-9602-A3AF62F0F467Q37703235-653FFE13-CD0C-44E0-8F37-F3A2A8D49129Q38100561-F5BAFFD9-C870-41EE-9C99-023117B9F14AQ39195751-5754AF3F-6072-4B87-B336-0C929106C8A9Q39232637-A7ABF975-CB2B-4591-A30F-D1325CC5229EQ39496047-C6DED54D-E9E8-4525-A7B9-AD7EE41CD41CQ42176376-131D4887-322B-4289-B7F2-1F32D277A977Q43059687-FF0043E2-4613-482C-A007-0E015E8835C9Q45871474-844D8403-8C4F-4E59-8E28-73D9242B7139Q48220185-6FE20BE1-A606-4CED-980B-DB84E011951BQ58794549-89F03FD9-4381-4DCC-AF7B-55356761AA87
P2860
Modeling of corneal and retinal pharmacokinetics after periocular drug administration
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Modeling of corneal and retinal pharmacokinetics after periocular drug administration
@ast
Modeling of corneal and retinal pharmacokinetics after periocular drug administration
@en
type
label
Modeling of corneal and retinal pharmacokinetics after periocular drug administration
@ast
Modeling of corneal and retinal pharmacokinetics after periocular drug administration
@en
prefLabel
Modeling of corneal and retinal pharmacokinetics after periocular drug administration
@ast
Modeling of corneal and retinal pharmacokinetics after periocular drug administration
@en
P2093
P2860
P356
P1476
Modeling of corneal and retinal pharmacokinetics after periocular drug administration
@en
P2093
Aniruddha C Amrite
Henry F Edelhauser
Uday B Kompella
P2860
P304
P356
10.1167/IOVS.07-0593
P407
P577
2008-01-01T00:00:00Z